Table 3.
Drugs/Drug Classes | Direct Inhibition of hERG K+ Channel. | Inhibition of hERG K+ Channel Trafficking |
---|---|---|
Phenothiazines | + | - |
Pentamidine | - | + |
Geldalamicin | - | + |
Ranolazine | + | - |
Arsenic Trioxide | - | + |
Fluoxetine, Norfluoxetine | + | + |
Ketoconazole | + | + |
Digitoxin, Ouabain, Digoxin | ? | + |
Sparfluoxacin,Ciprofloxacin, Ofloxacin | + | - |
Amsacrin | + | - |
Probucol | - | + |
Donepezil | + | + |
Tamoxifen, Endoxifen | + | + |
Berberine | ? | + |
Citalopram,Escitalopram, Fluoxetine, Norfluoxetine | + | + |
Atazanavir | + | + |
Roxitromycin | + | + |
Halofantrine,Chloroquine Mefloquine, Desbutyl-lumefantrine, Lumefantrine | + | ? |
Drug-induced inhibition of IKr currents can be achieved either by direct inhibition of potassium channels and/or by reducing the number of channels at the cell membrane. The latter is achieved by drug-induced impaired channel trafficking from the endoplasmic reticulum to the cell membrane. Data on drug-induced inhibition of channel trafficking is not available for all drugs.
Table taken with permission from Cubeddu [156]. Table content was modified and updated.